Clinical Trials Directory

Trials / Completed

CompletedNCT00854178

Toxicogenomic and Immunocytotoxic Effects of Propofol and Isoflurane Anesthetics in Patients Undergoing Elective Surgery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
26 (estimated)
Sponsor
UPECLIN HC FM Botucatu Unesp · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate if the anesthetics propofol and isoflurane can damage DNA, induce apoptosis, change expression of genes related to apoptosis and DNA repair and change cytokines profile in patients submitted to elective surgery.

Detailed description

It is expected that the results provide relevant information to understand the possible adverse effects of anesthetics and contribute to the establishment of strategies aimed at reducing the risks to exposed individuals.

Conditions

Interventions

TypeNameDescription
DRUGComparison of two anesthetic drugsIsoflurane 1,0 minimum alveolar concentration Propofol 2mg/kg and 4ug/ml

Timeline

Start date
2008-03-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2009-03-03
Last updated
2010-01-06

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT00854178. Inclusion in this directory is not an endorsement.

Toxicogenomic and Immunocytotoxic Effects of Propofol and Isoflurane Anesthetics in Patients Undergoing Elective Surgery (NCT00854178) · Clinical Trials Directory